Viewing Study NCT00640159


Ignite Creation Date: 2025-12-24 @ 2:51 PM
Ignite Modification Date: 2026-03-08 @ 5:55 AM
Study NCT ID: NCT00640159
Status: COMPLETED
Last Update Posted: 2023-08-09
First Post: 2008-03-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Selegiline to Zelapar Switch Study in Parkinson Disease Patients
Sponsor: Baylor College of Medicine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: H-20709
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators